News

To date, 607 patients have been enrolled in the study at more than 130 clinical trial sites in 23 countries. Total enrollment in this event-driven trial is targeted

PS031291 is a potent and highly selective antagonist at the chemokine receptor CCR1, which has been implicated to play a significant role in multiple inflammatory and autoimmune disease

Under the terms of the two agreements, Dyax is eligible to receive up to $500 million in license fees and milestone payments in the case of full commercial

The trial is a multi-centre, randomized, double-blind, double-dummy, crossover study to evaluate the safety and efficacy of fentanyl sublingual spray (AD 923) against an active comparator (morphine sulphate

This milestone officially marks the completion of the pivotal clinical trial of its investigational drug Sulonex (sulodexide oral gelcap) in the treatment of subjects with type 2 diabetes

Under the plan, the company will centralize the research and development activities supporting each of the company’s three main product families, as follows: Activities associated with North American

Genetic Immunity studied nine HIV infected individuals on fully suppressive antiretroviral therapy who were treated a single time with either 0.1, 0.4 or 0.8mg of multiple HIV antigens

The interim blinded HCV data showed that at the end of 48 weeks of therapy, 171 out of 553 total patients, including both treatment and control group patients,

Endologix’s Powerlink System is an endoluminal stent graft for treating abdominal aortic aneurysms. Paul McCormick, president and CEO of Endologix, said: “We will begin by shipping an initial